Meet our team.
Ilona Gorbovskaya, MSc
Research Manager
Institute of Medical Science | University of Toronto
Ilona received her MSc in Forensic Mental Health Research at King’s College London, UK and is currently pursuing a PhD in Medical Science at the University of Toronto. As a part of her PhD project, Ilona is investigating trait-based biomarkers of personality psychopathology with a primary focus on the traits which capture the phenotypic expression of Borderline Personality Disorder (BPD) and Antisocial Personality Disorders (ASPD). Ilona has been working at the Pharmacogenetics Research Clinic since 2016, where among many other things, she is responsible for setting up and conducting numerous research projects, including large multi-site clinical trials
Ilona’s Projects
Pharmacogenetics of Opioid Overdose
Antidepressant Response in Adults
Antipsychotics and the Gut Microbiome
Selected Publications
Investigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient Cohorts.
Gorbovskaya I, Kanji S, Liu JCW, MacKenzie NE, Agarwal SM, Marshe VS, Sriretnakumar V, Verdu EF, Bercik P, De Palma G, Hahn MK, Müller DJ. Neuropsychobiology. 2020;79(1):5-12.
Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
Maciukiewicz M, Tiwari AK, Zai CC, Gorbovskaya I, Laughlin CP, Nurmi EL, Liebermann JA, Meltzer HY, Kennedy JL, Müller DJ. Schizophr Res. 2019 Oct;212:204-212.
Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
Marshe VS, Gorbovskaya I, Kanji S, Kish M, Müller DJ. J Neural Transm (Vienna). 2019 Jan;126(1):65-85.
The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.
Raben AT, Marshe VS, Chintoh A, Gorbovskaya I, Müller DJ, Hahn MK. Front Neurosci. 2018 Jan 22;11:741.
Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
Maciukiewicz M, Gorbovskaya I, Tiwari AK, Zai CC, Freeman N, Meltzer HY, Kennedy JL, Müller DJ. J Neural Transm (Vienna). 2019 Jan;126(1):27-33.
Image credit: Freepik